* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download von Hippel
Gene therapy of the human retina wikipedia , lookup
Gene therapy wikipedia , lookup
Frameshift mutation wikipedia , lookup
Gene nomenclature wikipedia , lookup
Microevolution wikipedia , lookup
Transcription factor wikipedia , lookup
Primary transcript wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Designer baby wikipedia , lookup
Public health genomics wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Genome (book) wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Oncogenomics wikipedia , lookup
Point mutation wikipedia , lookup
von Hippel-Lindau Syndrome (VHL) Justin Melton von Hippel-Lindau Syndrome Multi-system disorder characterized by abnormal growth of blood vessels VHL the gene Tumor suppressor gene Inherited in an Autosomal Dominant fashion Mapped to chromosome 3p25-26 using genetic linkage analysis Has 3 exons encoding 4.7 kb mRNA Highly conserved sequence in rodents and primates Homologs in C. elegans and Drosphila pVHL the protein 213 amino acid protein Has 2 main binding or active sites (alpha and beta) Alpha site binds to an E3 ligase Beta site binds to HIF-1α – a transcription factor Inheritance Normal VHL Function Normal fuction important? Uh… YEAH! HIF transcription factor Knockout Mice Vhl-/- mice die in utero at day 10.5-12.5. Vhl+/- are phenotypically normal and show no signs of disease until up to 15 months. So what if we lose it in humans? Mutations Cont. VHL in Cancer Future Treatments? Usual cancer treatments: chemotherapy, cryotherapy, radiation and surgery. Hundreds of clinical trials currently taking place involving VHL in some fashion. Some target VHL specifically while others target downstream events, such as TGFβ transcription. Sources http://www.vhl.org Kim, William and Kaelin, William Jr. “The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.” Current Opinion 2003 13: pp55-60. Richards, Frances. “Molecular Pathology of von Hippel-Lindau disease and the VHL tumor suppressor gene.” Exp. Rev. Mol. Med. 19 March 2001. http://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=b v.View..ShowSection&rid=gnd.section.143 http://www.clinicaltrials.gov Questions?